Sign In
Buy TXG
$31.75
-0.470 (-1.46%)
At Close: Jun 16, 2026
TXG Gains From Proteintech Deal, Expands Multiomics Capabilities
02:07pm, Wednesday, 10'th Jun 2026
10x Genomics stock rises after acquiring Proteintech Genomics, adding high-plex proteomics tools that strengthen multiomics research and support platform adoption.
10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group
09:00am, Tuesday, 09'th Jun 2026
Acquisition Expands 10x Genomics' Capabilities in Proteomics PLEASANTON, Calif., June 9, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerati
10x Genomics, Inc. (TXG) Shareholder/Analyst Call Prepared Remarks Transcript
04:22pm, Thursday, 04'th Jun 2026
10x Genomics, Inc. (TXG) Shareholder/Analyst Call Prepared Remarks Transcript
10x Genomics CEO Sells Nearly 30,000 Shares. Here's What That Means for Investors.
02:03am, Monday, 01'st Jun 2026
10x Genomics, a leader in single cell and spatial genomics tools, reported a notable insider sale amid ongoing sector innovation.
10x Genomics, Inc. (TXG) Presents at Bank of America Global Healthcare Conference 2026 Transcript
11:00pm, Wednesday, 13'th May 2026
10x Genomics, Inc. (TXG) Presents at Bank of America Global Healthcare Conference 2026 Transcript
This $4 Million Bet Shows Growing Confidence in 10x Genomics as Stock Surges 116%
12:39pm, Tuesday, 12'th May 2026
10x Genomics provides advanced tools for single cell and spatial biology research, serving academic and biopharma institutions worldwide.
Torex Gold Resources Inc. (TXG:CA) Q1 2026 Earnings Call Transcript
10:31am, Saturday, 09'th May 2026
Torex Gold Resources Inc. (TXG:CA) Q1 2026 Earnings Call Transcript
10x Genomics Q1 Earnings Call Highlights
02:10am, Saturday, 09'th May 2026
10x Genomics NASDAQ: TXG reported a first-quarter revenue increase excluding prior-year settlement revenue and used its earnings call to emphasize the launch of Atera, a new spatial biology instrument
10x Genomics Q1 Earnings & Revenues Beat Estimates, Gross Margin Up
11:45am, Friday, 08'th May 2026
TXG beats Q1 estimates as consumables growth, margin expansion and lower operating costs narrow losses year over year.
10x Genomics, Inc. (TXG) Q1 2026 Earnings Call Transcript
01:01am, Friday, 08'th May 2026
10x Genomics, Inc. (TXG) Q1 2026 Earnings Call Transcript
10x Genomics (TXG) Reports Q1 Loss, Beats Revenue Estimates
07:01pm, Thursday, 07'th May 2026
10x Genomics (TXG) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.36 per share a year ago.
10x Genomics (TXG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
07:01pm, Thursday, 07'th May 2026
While the top- and bottom-line numbers for 10x Genomics (TXG) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compa
10x Genomics Reports First Quarter 2026 Financial Results
04:05pm, Thursday, 07'th May 2026
PLEASANTON, Calif., May 7, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31, 2
10x Genomics (TXG) Expected to Beat Earnings Estimates: Should You Buy?
11:06am, Thursday, 30'th Apr 2026
10x Genomics (TXG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference
04:05pm, Wednesday, 29'th Apr 2026
PLEASANTON, Calif., April 29, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate i
